👋 Welcoming the @DHSCgovuk 10 Year Health Plan. NICE CEO Dr Sam Roberts discusses how the plan strengthens NICE's role in speeding up access to the best care while ensuring taxpayer value⤵️.

📢Join NICE as: Associate Director - Research and lead our innovative research portfolio and HTA Innovation Lab. Help secure funding, shape evidence-based healthcare policy and collaborate with experts globally. 📍London/Manchester.📝Apply by 14 July:

Just over 64,500 people with moderate to severe eczema could be set to benefit from a new treatment option. Learn more about Nemolizumab:.

The 10 Year Health Plan gives NICE the power to get medicines to patients faster, reduces the postcode lottery for high impact healthtech, and maximises the value for money of existing innovations used in the NHS. Read more in NICE CEO Dr Sam Roberts blog post👇.

People with previously treated advanced bowel cancer could be set to benefit from a new once-a-day pill treatment. Learn more about Fruquintinib:

The publication of the 10 Year Health Plan represents a significant milestone in our collective vision of an NHS fit for the future. At NICE, we are ready to embrace our expanded role and responsibilities in making this ambition a reality.

RT @DHSCgovuk: Our 10 Year Health Plan. We’re making the NHS fit for the future.

RT @DHSCgovuk: 👨👩‍⚕️ We will only make the NHS fit for the future with the help of the people who use it and work in it. 📍 That's why we t….

People with chronic kidney disease are set to benefit after we recommended a new tablet treatment today. Find out more about dapagliflozin⤵️ .

@DHSCgovuk @MHRAgovuk We also welcome measures to treat medicines and health technologies equally in the 10 Year Health Plan, until now this principle only applied to medicines. Learn more⤵️.

NICE welcomes the new joint regulatory plan as part of the @DHSCgovuk 10 Year Health Plan. We look forward to working closely with @MHRAgovuk and others to help the health and care system deliver innovative treatments that improve patient outcomes while ensuring value for money.

Do you have lived experience of asthma?. Help shape the future of digital self-management tools, by joining NICE as a lay specialist committee member to evaluate technologies that could improve health outcomes for people with asthma. Apply by 16 July ⬇️.

RT @DHSCgovuk: 🗣️ Your views, experiences and ideas have helped shape our upcoming 10 Year Health Plan. 🙌 Thank you to everyone who took p….

RT @DHSCgovuk: 🤖 From the NHS App to AI and robotics, tech and innovation is central to our 10 Year Health Plan. @WesStreeting tries out….

Around 250 people with mantle cell lymphoma will benefit from NICE's recommendation of zanubrutinib (Brukinsa), providing an additional treatment option for this rare and aggressive blood cancer when it has relapsed or become resistant

📢Our updated technology evaluation methods will help tackle health inequalities across communities. Read how NICE is ensuring fairer health outcomes in our blog post:

Thousands of people with chronic kidney disease could benefit after our independent committee recommended a new treatment option for use in the NHS today. Find more about sparsentan for treating primary IgA nephropathy:

📱 When children's mental health services faced surging demand, East London NHS adopted a digital solution. Dale Greenwood explains how NICE healthtech guidance helped his trust implement a digital therapy app for children with anxiety. Read more:

Join our NICE Advice seminar (24 June) for pharma teams and consultancies, to strengthen your submission strategy. Learn about:.▪️real-world data & AI.▪️health inequalities .▪️presenting surrogate outcomes. Develop stronger evidence with expert support⤵️.

Explore our guideline on maternal and child nutrition⤵️.